Search research articles
Contact Us
Filters
Showing results (11-20 of 56) with videos related to
Page
of 6
Sort By:
Journal of Medicinal Chemistry
|
November 1, 1980
Synthesis and some pharmacological properties of [8-L-tryptophan]oxytocin
M Bodanszky, J C Tolle, J Seto, et al.
The British Journal of Ophthalmology
|
April 20, 2004
Contrast and glare testing in keratoconus and after penetrating keratoplasty
K Pesudovs, P Schoneveld, R J Seto, et al.
Neuroscience
|
August 21, 2003
The fragile X mental retardation protein binds and regulates a novel class of mRNAs containing U rich target sequences
L Chen, S W Yun, J Seto, et al.
Virology
|
September 1, 1987
Genetic map of the vaccinia virus HindIII D Fragment
J Seto, L M Celenza, R C Condit, et al.
International Journal of Peptide and Protein Research
|
November 1, 1980
Design and synthesis of potent in vivo antagonists of oxytocin
K Bankowski, M Manning, J Seto, et al.
Journal of Medicinal Chemistry
|
May 1, 1979
Synthetic antagonists of in vivo responses by the rat uterus to oxytocin
J Lowbridge, M Manning, J Seto, et al.
Journal of Medicinal Chemistry
|
October 1, 1985
Synthesis and some pharmacological properties of 18 potent O-alkyltyrosine-substituted antagonists of the vasopressor responses to arginine-vasopressin
M Manning, B Lammek, K Bankowski, et al.
Journal of Medicinal Chemistry
|
February 1, 1978
[1-Deaminopenicillamine,4-threonine]oxytocin, a potent inhibitor of oxytocin
M Manning, J Lowbridge, J Seto, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada
|
May 18, 2018
What are Canadian primary care physicians prescribing for the treatment of gonorrhea?
S Ha, L Pogany, J Seto, et al.
Journal of Medicinal Chemistry
|
November 1, 1983
Potent antagonists of the antidiuretic responses to arginine-vasopressin based on modifications of [1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid),2-D- phenylalanine,4-valine]arginine-vasopressin at position 4
M Manning, A Olma, W A Klis, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 56) with videos related to
Sort By:
Page
of 6
Journal of Medicinal Chemistry
|
November 1, 1980
Synthesis and some pharmacological properties of [8-L-tryptophan]oxytocin
M Bodanszky, J C Tolle, J Seto, et al.
The British Journal of Ophthalmology
|
April 20, 2004
Contrast and glare testing in keratoconus and after penetrating keratoplasty
K Pesudovs, P Schoneveld, R J Seto, et al.
Neuroscience
|
August 21, 2003
The fragile X mental retardation protein binds and regulates a novel class of mRNAs containing U rich target sequences
L Chen, S W Yun, J Seto, et al.
Virology
|
September 1, 1987
Genetic map of the vaccinia virus HindIII D Fragment
J Seto, L M Celenza, R C Condit, et al.
International Journal of Peptide and Protein Research
|
November 1, 1980
Design and synthesis of potent in vivo antagonists of oxytocin
K Bankowski, M Manning, J Seto, et al.
Journal of Medicinal Chemistry
|
May 1, 1979
Synthetic antagonists of in vivo responses by the rat uterus to oxytocin
J Lowbridge, M Manning, J Seto, et al.
Journal of Medicinal Chemistry
|
October 1, 1985
Synthesis and some pharmacological properties of 18 potent O-alkyltyrosine-substituted antagonists of the vasopressor responses to arginine-vasopressin
M Manning, B Lammek, K Bankowski, et al.
Journal of Medicinal Chemistry
|
February 1, 1978
[1-Deaminopenicillamine,4-threonine]oxytocin, a potent inhibitor of oxytocin
M Manning, J Lowbridge, J Seto, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada
|
May 18, 2018
What are Canadian primary care physicians prescribing for the treatment of gonorrhea?
S Ha, L Pogany, J Seto, et al.
Journal of Medicinal Chemistry
|
November 1, 1983
Potent antagonists of the antidiuretic responses to arginine-vasopressin based on modifications of [1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid),2-D- phenylalanine,4-valine]arginine-vasopressin at position 4
M Manning, A Olma, W A Klis, et al.
Page
of 6